In a recent study conducted in Canada and involving 1,154 patients with invasive pneumococcal disease, Marrie et al. found that being 18-40 years of age and receiving concurrent treatment with two antibiotics were associated with lower mortality.
En un estudio reciente sobre 1.154 pacientes con enfermedad neumocócica invasiva realizado en Canadá, Marrie et al. encontraron que se asociaron a menor mortalidad la edad entre 18 y 40 años y el tratamiento con 2 antibióticos en forma concurrente.